Organization Profile

You just read:

New data analysis of EXAMINE cardiovascular safety outcomes trial of Takeda type 2 diabetes treatment alogliptin published in The Lancet

News provided by

Takeda Canada Inc.

May 26, 2015, 05:59 ET